Optimal controlling of anti-TGF-$$\beta$$ and anti-PDGF medicines for preventing pulmonary fibrosis
Crossref DOI link: https://doi.org/10.1038/s41598-023-41294-z
Published Online: 2023-09-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bahram Yazdroudi, Fatemeh
Malek, Alaeddin
Text and Data Mining valid from 2023-09-12
Version of Record valid from 2023-09-12
Article History
Received: 28 May 2023
Accepted: 24 August 2023
First Online: 12 September 2023
Competing Interests
: The authors declare no competing interests.